Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Run-in Period: Placebo (Week-4 to Day 1)	STARTED	Daprodustat	1,937
Run-in Period: Placebo (Week-4 to Day 1)	STARTED	Darbepoetin Alfa	1,935
Run-in Period: Placebo (Week-4 to Day 1)	COMPLETED	Daprodustat	1,937
Run-in Period: Placebo (Week-4 to Day 1)	COMPLETED	Darbepoetin Alfa	1,935
Run-in Period: Placebo (Week-4 to Day 1)	NOT COMPLETED	Daprodustat	0
Run-in Period: Placebo (Week-4 to Day 1)	NOT COMPLETED	Darbepoetin Alfa	0
Treatment Period (51.1 Month)	STARTED	Daprodustat	1,937
Treatment Period (51.1 Month)	STARTED	Darbepoetin Alfa	1,935
Treatment Period (51.1 Month)	COMPLETED	Daprodustat	1,873
Treatment Period (51.1 Month)	COMPLETED	Darbepoetin Alfa	1,870
Treatment Period (51.1 Month)	NOT COMPLETED	Daprodustat	64
Treatment Period (51.1 Month)	NOT COMPLETED	Darbepoetin Alfa	65

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02876835/flow